News | Magnetic Resonance Imaging (MRI) | May 03, 2017

MR Solutions Wins Second Straight Queen's Award for Enterprise in the U.K.

Cryogen-free preclinical MRI systems help reduce costs, eliminate cumbersome cooling and venting equipment

MR Solutions Wins Second Straight Queen's Award for Enterprise in the U.K.

May 3, 2017 — MR Solutions won the prestigious Queen’s Award for Enterprise for International Trade in late April. These awards are announced on the Queen’s birthday, April 21, and are one of the U.K.’s highest accolades recognizing business achievement. Last year MR Solutions won the Queen’s Award for Innovation.

This has been achieved in recognition of MR Solutions’ business success, with strong export sales growth of 119 percent over the last three years. The company said this success has been driven by its investment in the development and commercialization of their cryogen-free preclinical magnetic resonance imaging (MRI) technology that can be combined with other imaging capabilities such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). 

Cryogen-free has many advantages for the researchers, not the least being cost. These advantages include doing away with the cumbersome helium cooling jacket and the emergency venting equipment that was necessary to vent the helium should the magnet quench.  It also does away with the extensive building works involved in installing the venting system and these very large machines. The cryogen-free scanner can just be wheeled in.

MR Solutions was able to develop an MRI system using a novel magnet design that only needs a readily available cryocooler unit to get to the very low temperature required. The company’s 3T to 9.4T MRI benchtop scanners are used in research laboratories across the world and can be installed alongside other equipment because the innovative design has reduced the stray magnetic field from meters to centimeters.

For more information: www.mrsolutions.com

Related Content

Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...